PTK7 as a novel marker for favorable gastric cancer patient survival

Journal of Surgical Oncology

Volumn 106, Issue 7, 2012, Pages 880-886

  Lin, Yi ^a   Zhang, Lian Hai ^a   Wang, Xiao Hong ^a   Xing, Xiao Fang ^a   Cheng, Xiao Jing ^a   Dong, Bin ^a   Hu, Ying ^a   Du, Hong ^a   Li, Ying Ai ^a   Zhu, Yu Bing ^a   Ding, Ning ^a   Du, Yun Xia ^a   Li, Ji You ^a   Ji, Jia Fu ^a  

^a PEKING UNIVERSITY CANCER HOSPITAL AND INSTITUTE   (China)

Author keywords

biomarker; prognosis; protein tyrosine kinase 7; stomach neoplasms

Indexed keywords

PROTEIN TYROSINE KINASE; PROTEIN TYROSINE KINASE 7; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER PROGNOSIS; CANCER SURVIVAL; CONTROLLED STUDY; CYTOPLASM; DISEASE ASSOCIATION; DISEASE FREE SURVIVAL; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; STOMACH CANCER;

AGED; CASE-CONTROL STUDIES; CELL ADHESION MOLECULES; COHORT STUDIES; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PROGNOSIS; RECEPTOR PROTEIN-TYROSINE KINASES; STOMACH NEOPLASMS; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 84868375056     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.23154     Document Type: Article

References (35)

1. Kamangar F, Dores GM, Anderson WF:, Patterns of cancer incidence, mortality, and prevalence across five continents: Defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol 2006; 24: 2137-2150.
2. Jemal A, Bray F, Center MM, et al.: Global cancer statistics. CA Cancer J Clin 2011; 61: 69-90.
3. Siegel R, Ward E, Brawley O, et al.: Cancer statistics, 2011: The impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin 2011; 61: 212-236.
4. Suh YS, Lee HJ, Jung EJ, et al.: The combined expression of metaplasia biomarkers predicts the prognosis of gastric cancer. Ann Surg Oncol 2012; 19: 1240-1249.
5. Warneke VS, Behrens HM, Hartmann JT, et al.: Cohort study based on the seventh edition of the TNM classification for gastric cancer: Proposal of a new staging system. J Clin Oncol 2011; 29: 2364-2371.
6. Jung JW, Shin WS, Song J, et al.: Cloning and characterization of the full-length mouse Ptk7 cDNA encoding a defective receptor protein tyrosine kinase. Gene 2004; 328: 75-84.
7. Easty DJ, Mitchell PJ, Patel K, et al.: Loss of expression of receptor tyrosine kinase family genes PTK7 and SEK in metastatic melanoma. Int J Cancer J Int Cancer 1997; 71: 1061-1065.
8. Shaheen RM, Ahmad SA, Liu W, et al.: Inhibited growth of colon cancer carcinomatosis by antibodies to vascular endothelial and epidermal growth factor receptors. Br J Cancer 2001; 85: 584-589.
9. Mossie K, Jallal B, Alves F, et al.: Colon carcinoma kinase-4 defines a new subclass of the receptor tyrosine kinase family. Oncogene 1995; 11: 2179-2184.
10. Muller-Tidow C, Schwable J, Steffen B, et al.: High-throughput analysis of genome-wide receptor tyrosine kinase expression in human cancers identifies potential novel drug targets. Clin Cancer Res Off J Am Assoc Cancer Res 2004; 10: 1241-1249.
11. Gobble RM, Qin LX, Brill ER, et al.: Expression profiling of liposarcoma yields a multigene predictor of patient outcome and identifies genes that contribute to liposarcomagenesis. Cancer Res 2011; 71: 2697-2705.
12. Prebet T, Lhoumeau AC, Arnoulet C, et al.: The cell polarity PTK7 receptor acts as a modulator of the chemotherapeutic response in acute myeloid leukemia and impairs clinical outcome. Blood 2010; 116: 2315-2323.
13. Japanese Gastric Cancer Association.: Japanese classification of gastric carcinoma: 3rd English edition. Gastric Cancer Off J Int Gastric Cancer Assoc Jap Gastric Cancer Assoc 2011; 14: 101-112.
14. Ajani JA, Barthel JS, Bekaii-Saab T, et al.: Gastric cancer. J Natl Compr Cancer Netw 2010; 8: 378-409.
15. Wang XH, Zhang LH, Zhong XY, et al.: S100A6 overexpression is associated with poor prognosis and is epigenetically up-regulated in gastric cancer. Am J Pathol 2010; 177: 586-597.
16. Xing XF, Li H, Zhong XY, et al.: Phospholipase A2 group IIA expression correlates with prolonged survival in gastric cancer. Histopathology 2011; 59: 198-206.
17. Cervantes A, Rosello S, Roda D, et al.: The treatment of advanced gastric cancer: Current strategies and future perspectives. Ann Oncol Off J Eur Soc Med Oncol/ESMO 2008; 19: v103-v107.
18. Lo SL, Thike AA, Tan SY, et al.: Expression of heparan sulfate in gastric carcinoma and its correlation with clinicopathological features and patient survival. J Clin Pathol 2011; 64: 153-158.
19. Ogata K, Aihara R, Mochiki E, et al.: Clinical significance of melanoma antigen-encoding gene-1 (MAGE-1) expression and its correlation with poor prognosis in differentiated advanced gastric cancer. Ann Surg Oncol 2011; 18: 1195-1203.
20. Otsubo T, Akiyama Y, Yanagihara K, et al.: SOX2 is frequently downregulated in gastric cancers and inhibits cell growth through cell-cycle arrest and apoptosis. Br J Cancer 2008; 98: 824-831.
21. Matsuoka J, Yashiro M, Sakurai K, et al.: Role of the stemness factors Sox2, Oct3/4, and Nanog in gastric carcinoma. J Surg Res 2012; 19: 130-135.
22. Katoh M:, Comparative integromics on non-canonical WNT or planar cell polarity signaling molecules: Transcriptional mechanism of PTK7 in colorectal cancer and that of SEMA6A in undifferentiated ES cells. Int J Mol Med 2007; 20: 405-409.
23. Shin WS, Maeng YS, Jung JW, et al.: Soluble PTK7 inhibits tube formation, migration, and invasion of endothelial cells and angiogenesis. Biochem Biophys Res Commun 2008; 371: 793-798.
24. Paudyal A, Damrau C, Patterson VL, et al.: The novel mouse mutant, chuzhoi, has disruption of Ptk7 protein and exhibits defects in neural tube, heart and lung development and abnormal planar cell polarity in the ear. BMC Dev Biol 2010; 10: 87-109.
25. Shnitsar I, Borchers A:, PTK7 recruits DSH to regulate neural crest migration. Development 2008; 135: 4015-4024.
26. Yen WW, Williams M, Periasamy A, et al.: PTK7 is essential for polarized cell motility and convergent extension during mouse gastrulation. Development 2009; 136: 2039-2048.
27. Lu XW, Borchers AGM, Jolicoeur C, et al.: PTK7/CCK-4 is a novel regulator of planar cell polarity in vertebrates. Nature 2004; 430: 93-98.
28. Savory JG, Mansfield M, Rijli FM, et al.: Cdx mediates neural tube closure through transcriptional regulation of the planar cell polarity gene Ptk7. Development 2011; 138: 1361-1370.
29. Wehner P, Shnitsar I, Urlaub H, et al.: RACK1 is a novel interaction partner of PTK7 that is required for neural tube closure. Development 2011; 138: 1321-1327.
30. Peradziryi H, Kaplan NA, Podleschny M, et al.: PTK7/Otk interacts with Wnts and inhibits canonical Wnt signalling. EMBO J 2011; 30: 3729-3740.
31. Lhoumeau AC, Puppo F, Prebet T, et al.: PTK7: A cell polarity receptor with multiple facets. Cell Cycle 2011; 10: 1233-1236.
32. Puppo F, Thome V, Lhoumeau AC, et al.: Protein tyrosine kinase 7 has a conserved role in Wnt/beta-catenin canonical signalling. EMBO Rep 2011; 12: 43-49.
33. Endoh H, Tomida S, Yatabe Y, et al.: Prognostic model of pulmonary adenocarcinoma by expression profiling of eight genes as determined by quantitative real-time reverse transcriptase polymerase chain reaction. J Clin Oncol 2004; 22: 811-819.
34. Meng L, Sefah K, O'Donoghue MB, et al.: Silencing of PTK7 in colon cancer cells: Caspase-10-dependent apoptosis via mitochondrial pathway. PLoS ONE 2010; 5: e14018.
35. Alonzo TA:, Standards for reporting prognostic tumor marker studies. J Clin Oncol 2005; 23: 9053-9054.